Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
Top Cited Papers
Abstract
No abstract availableKeywords
Funding Information
- Philips
- National Heart, Lung, and Blood Institute (1K23HL146982-01A1)
- Abbott Vascular
- AstraZeneca
- American Heart Association (17MCPRP33630098)
- Sanofi
- Medtronic
- Center for Social Inclusion
- Abbott Laboratories
- Boston Scientific Corporation
This publication has 3 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s HospitalIntensive Care Medicine, 2020
- Preparedness of the cardiac catheterization laboratory for severe acute respiratory syndrome (SARS) and other epidemics.2005